How we are helping to accelerate the pace of lung cancer detection.
Our team at Paul Strickland Scanner Centre is supporting the delivery of a new lung cancer blood screening clinical research trial by Accellacare, the global clinical research network.
This trial is aimed at advancing existing testing that is available for lung cancer by identifying cancer biomarkers in the blood.
The NHS Long Term Plan aims to save thousands of lives each year by dramatically improving how we diagnose and treat cancer, and population screening plays a vital role in the early detection of the disease.
This trial is open to healthy volunteers aged between 50-80 who are smokers and have not had a cancer diagnosis.
The participants must be willing to undergo blood tests, general medical checks and CT lung scans.
The scan uses no injections and it will take 30 seconds. Following this they will be required to return regularly for follow up blood tests and CT scans.
Hema Clark, Research Radiographer at Paul Strickland Scanner Centre, said: “I’m very excited that we are able to contribute to this valuable research that will help improve the early diagnosis of lung cancer by performing the CT scans for this study.” Paul Strickland Scanner Centre is a recognised centre of excellence for cancer imaging and our Siemens FORCE CT scanner allows us to perform high quality, low dose scans for our patients.
If you or your friends and family would like to know more about this trial or are considering participating, register your interest by completing an online form at www.improvingtreatments.co.uk/join-a-study/cancer-bloodscreening/lung-cancer-bloodscreening or by calling 020 3019 8766.
